HBOX Founding team

About HBOX Therapies

HBOX Therapies has developed a technology that facilitates lung-protective treatment of respiratory patients, the patented platform technology HBOX (Hyperbaric Blood Oxygenation). The management team of HBOX Therapies consists of the founders and shareholders Dr. Peter Schlanstein, Dr. Matthias Menne and Niklas Steuer. Before founding the company, they worked together for many years at the Institute for Applied Medical Technology (AME) at RWTH Aachen University and are highly specialized in their fields.

Press releases

HBOX Founding team
22. February 2023

MedTech startup HBOX Therapies receives €2.3m in seed funding for protective lung support

The medtech start-up develops innovative treatment method for patients with lung failure. HBOX Therapies receives €2.3 million in seed funding from TechVision Fonds (TVF), High-Tech Gründerfonds (HTGF) and business angel Prof. Dr. Peter Borges. The fresh capital will be used to develop and test a first prototype, marking an important step towards clinical trials. Aachen, 22 February 2023 – HBOX Therapies raises €2.3m in seed funding. The round is led by TVF, with pa

Info & Contact


HBOX Therapies GmbH
Kuhlweg 42
52074 Aachen

In portfolio

02. Feb 2023

Dr. Caroline Fichtner

Principal / Authorized Signatory